One particularity of PACAP is that it counteracts many of the deleterious processes activated by stroke through its anti-excitotoxicity, anti-apoptotic, anti-inflammatory, antioxidant, and immuno-modulatory activities (28–31). Here, ADCYAP1 is linked to stroke disorder.